|
Native Antigen Inc
zikv ns1 ![]() Zikv Ns1, supplied by Native Antigen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/Zika+Virus+NS1+Protein+(Uganda+Strain)/pmc08442231-137-14-19 Average 94 stars, based on 1 article reviews
zikv ns1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
BioFront Technologies Inc
anti-zikv ns1 elisa kit (zkv-ns1-ek) ![]() Anti Zikv Ns1 Elisa Kit (Zkv Ns1 Ek), supplied by BioFront Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/anti+zikv+ns1/pmc05386783-473-1-9 Average 90 stars, based on 1 article reviews
anti-zikv ns1 elisa kit (zkv-ns1-ek) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Verlag GmbH
anti-zikv-ns1 igg ![]() Anti Zikv Ns1 Igg, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/anti+zikv+ns1+igg/pm32646188-90-25-7 Average 90 stars, based on 1 article reviews
anti-zikv-ns1 igg - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GeneTex
anti-zikv ns1 ![]() Anti Zikv Ns1, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/rabbit+anti+zikv+ns1/pm38483048-69-43-45 Average 90 stars, based on 1 article reviews
anti-zikv ns1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Alpha Diagnostics
rabbit igg anti-zikv prm ![]() Rabbit Igg Anti Zikv Prm, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/rabbit+anti+zikv+ns1+antiserum/us10240130-241-61-69 Average 90 stars, based on 1 article reviews
rabbit igg anti-zikv prm - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Immunodiagnostic Systems
anti-ns1 zikv 3c2 monoclonal antibody ![]() Anti Ns1 Zikv 3c2 Monoclonal Antibody, supplied by Immunodiagnostic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/anti+ns1+zikv+3c2+monoclonal+antibody/pmc06764950__41467_2019_12408_MOESM1_ESM-3-7-13 Average 90 stars, based on 1 article reviews
anti-ns1 zikv 3c2 monoclonal antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Covance
monoclonal antibody production strategy denv and zikv anti-ns1 monoclonal antibodies ![]() Monoclonal Antibody Production Strategy Denv And Zikv Anti Ns1 Monoclonal Antibodies, supplied by Covance, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/monoclonal+antibody+production+strategy+denv+and+zikv+anti+ns1+monoclonal+antibodies/pmc06612058-473-6-16 Average 90 stars, based on 1 article reviews
monoclonal antibody production strategy denv and zikv anti-ns1 monoclonal antibodies - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
BioNano Genomics
anti-zikv ns1 monoclonal antibody ![]() Anti Zikv Ns1 Monoclonal Antibody, supplied by BioNano Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+zikv+ns1/anti+zikv+ns1+monoclonal+antibody/pmc08166042-55-7-18 Average 90 stars, based on 1 article reviews
anti-zikv ns1 monoclonal antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Zika virus NS1 antigen is one of seven non-structural proteins. NS1 is involved in RNA replicaiton. The possible effects of NS1 on hosts include: localization to host cell surface and secreted extracellularly, modelates signalling of
|
Buy from Supplier |
|
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Zika virus (ZIKV) (strain Zika SPH2015) ZIKV-NS1 ( Catalog#40544-V07H;
|
Buy from Supplier |
Image Search Results
Journal: Immunology
Article Title: Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity
doi: 10.1111/imm.13380
Figure Lengend Snippet: Isotype specificity of ZIKV‐immune sera. ELISA plates were coated with ZIKV NS1 (a, c) or ZIKV VLP (b, d), and a 1:100 dilution ( n = 28) (a, b) or serial dilutions ( n = 11) (c, d) of ZIKV‐immune sera were added to plates. Following incubation and washes, optimized concentrations of polyclonal secondary IgG, and monoclonal Abs against the hinge or Fc portion of IgG1, IgG2, IgG3 and IgG4 Abs were added to wells (a) and (b) and IgG1 hinge Abs to (c) and (d). OD values shown at 450 nm. OD values to ZIKV VLP and ZIKV NS1 using a 1:100 dilution of ZIKV‐naïve sera ( n = 4), <0·2 with polyclonal secondary IgG and <0·1 with IgG1 hinge, IgG1 Fc, IgG2, IgG3 and IgG4 secondary Abs. Bars represent mean with standard error of the mean of the OD values. * P < 0·05, *** P < 0·001 and **** P < 0·0001 were obtained using the non‐parametric Friedman test (three or more matched groups) with Dunn's multiple comparisons test
Article Snippet: We generated CEM‐NK R cells stably expressing
Techniques: Enzyme-linked Immunosorbent Assay, Incubation
Journal: Immunology
Article Title: Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity
doi: 10.1111/imm.13380
Figure Lengend Snippet: Frequencies of ZIKV‐specific IgG and IgG1 B‐cell responses using fluorescently labelled ZIKV or ZIKV NS1. PBMCs from ZIKV‐immune and ZIKV‐naïve donors were stimulated in vitro for seven days with r848 + rIL‐2. FluoroSpot plates were coated with IgG and IgG1 capture Abs. (a) Images of wells containing media, total IgG, ZIKV and ZIKV NS1 IgG‐ or IgG1‐specific MBCs from one representative donor. (b) Frequencies of ZIKV (green) and NS1‐specific (red) ASCs per 10 6 input cells in MBC cultures from 12 ZIKV‐immune and three ZIKV‐naïve donors. Values are the mean of duplicate wells for each condition. The supernatants were evaluated for isotype‐specific Abs to (c) ZIKV VLPs and (D) ZIKV NS1. * P < 0·05, ** P < 0·01 and **** P < 0·0001 were obtained using the non‐parametric Mann‐Whitney or Friedman test (three or more matched groups) with Dunn's multiple comparisons test
Article Snippet: We generated CEM‐NK R cells stably expressing
Techniques: In Vitro, MANN-WHITNEY
Journal: Immunology
Article Title: Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity
doi: 10.1111/imm.13380
Figure Lengend Snippet: Opsonization and ADCC activity of a ZIKV NS1 monoclonal Ab. (a) K562 cells transfected with DC‐SIGN were infected with ZIKV (moi = 0·1 and 1), and 24 h later, the expression of E and NS1 was measured with monoclonal Abs 4G2 and B4 respectively. (b) Opsonization of ZIKV NS1‐transfected CEM‐NK R cells with a mAb to ZIKV NS1 from Native Antigen Company. CEM‐NK R cells transfected with ZIKV NS1 (c and d) or control CEM‐NK R cells (e and f) were opsonized with a ZIKV NS1 mAb (d and f), added to PBMC. A standard lymphocyte gate based upon light scatter properties followed by selection of singlet viable cells and dump channel exclusion (CD3 − T cells) defined the non‐T‐cell lymphocyte population, and Abs to CD16 and CD56 identified NK cells
Article Snippet: We generated CEM‐NK R cells stably expressing
Techniques: Activity Assay, Transfection, Infection, Expressing, Selection
Journal: Immunology
Article Title: Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity
doi: 10.1111/imm.13380
Figure Lengend Snippet: NK cell activation and degranulation in the presence of ZIKV‐immune sera. 1:100 dilution and 1:1600 dilution of polyclonal sera from ZIKV‐immune individuals were evaluated for their ability to mediate ADCC of ZIKV NS1 CEM‐NK R cells using intracellular cytokine assays. Shown are the frequencies of NK cells that (a) secrete IFN‐γ, (B) express CD107 or (C) express both CD107 and IFN‐γ in the presence of ZIKV‐immune sera. Background levels were subtracted
Article Snippet: We generated CEM‐NK R cells stably expressing
Techniques: Activation Assay
Journal: Immunology
Article Title: Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity
doi: 10.1111/imm.13380
Figure Lengend Snippet: Opsonization and target cell lysis using an NK‐TVA image cytometry assay. (a) Opsonization of ZIKV NS1 CEM‐NK R cells by ZIKV convalescent sera. (b) Representative images of wells acquired by an ImmunoSpot S5 Analyser of an NK‐TVA assay where ethanol, ZIKV NS1 or IgG Ab was added to the wells containing effector and target cells. (c) Using an optimized number of target cells, effector PBMC as a source of NK cells and different dilutions of naïve sera ( n = 5), positive control sera that opsonized ZIKV NS1 CEM‐NK R targets ( n = 5) and experimental sera ( n = 12), the loss of target cells at the single‐cell level was measured by the NK‐TVA image cytometry assay and calculated as a percentage of lysed target cells. * P < 0·05 and ** P < 0·01 were obtained using a Kruskal–Wallis test with Dunn's multiple comparisons test
Article Snippet: We generated CEM‐NK R cells stably expressing
Techniques: Lysis, Cytometry, Positive Control
Journal: Nature medicine
Article Title: Identification of small molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
doi: 10.1038/nm.4184
Figure Lengend Snippet: Identification of PHA-690509 and Niclosamide as antiviral compounds. (a) Top, example western blot images of titration of PHA-690509 on SNB-19 cells for anti-ZIKV activity. Glioblastoma SNB-19 cells were treated with the indicated compound for 1 hour prior to inoculation with ZIKV FSS-13025, PRVABC59, or MR766 (MOI = 1) and cells were harvested 24 hours post infection for western blot analysis. Bottom, quantification of NS1/GAPDH protein band intensities. Data were normalized to that with the DMSO treatment. Values represent mean ± s.d. (n = 3 cultures; ***P < 0.001; One-way ANOVA for comparison with the DMSO treatment). Insert shows chemical structure of PHA-690509. (b) Top, example western blot images of titration of Emricasan on SNB-19 cells for anti-ZIKV activity. Similar to (a). Values represent mean ± s.d. (n = 3 cultures; P > 0.1; One-way ANOVA for comparison with the DMSO treatment). (c) Top, chemical structure of Niclosamide and example western blot images of titration of Niclosamide on SNB-19 cells for anti-ZIKV activity using the PRVABC59 strain (MOI = 1). Bottom, quantification similar to (a). Values represent mean ±s.d. (n = 3 cultures; **P < 0.01; ***P < 0.001; One-way ANOVA for comparison with the DMSO treatment). (d) Summary of ELISA quantifications of secreted ZIKV-NS1 protein in the medium of infected cells upon treatment of different doses of Niclosamide (top) or PHA-690509 (bottom) for 24 hours. Values represent mean ± s.d. (n = 3 cultures; ***P < 0.001; One-way ANOVA for comparison with the 0 μM group). (e) Summary of titration of Niclosamide and PHA-690509 on ZIKV viral production. SNB-19 cells were treated with each indicated compound at increasing concentrations for 1 hour prior to infection with PRVABC59 at MOI = 0.5. Cell culture supernatant was collected 24 hours post infection and infectious virions were quantified for focus-forming units (FFU) using Vero cells. Data represent mean ± s.d. (n = 3 cultures). Curves represent best fits for calculating IC50, and the insets report the calculated IC50 value for each compound.
Article Snippet: The
Techniques: Western Blot, Titration, Activity Assay, Infection, Enzyme-linked Immunosorbent Assay, Cell Culture
Journal: Nature medicine
Article Title: Identification of small molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
doi: 10.1038/nm.4184
Figure Lengend Snippet: Inhibition of ZIKV infection by Niclosamide and PHA-690509 at a post-entry step and blockade of ZIKV infection by additional CDKis. (a) Schematic illustration of time-of-addition experiment for Niclosamide and PHA-690509. (b) Top, example western blot images of SNB-19 cells treated with 10 μg/ml anti-AXL antibody, 2 μM Niclosamide, or 92 μM PHA-690509 for 1 hour prior to or 4 hours post infection with PRVABC59 (MOI = 1). Bottom, quantification of NS1/GAPDH protein band intensities. Data were normalized to that with the DMSO treatment. Values represent mean ± s.d. (n = 3 cultures; *P < 0.05; **P < 0.01; ***P < 0.001; One-way ANOVA for comparison with the DMSO treatment). (c) Inhibition of ZIKV infection in CDKi-treated cells. Left, example western blot images of SNB-19 cells treated with the indicated compound at 92 μM for one hour prior to infection with FSS13025 or PRVABC59 (MOI = 1). Right, quantification similar to (b). Values represent mean ± s.d. (n = 3 cultures; ***P < 0.01; One-way ANOVA for comparison with the DMSO treatment). (d) Effect of various CDKis on ZIKV production. Similar to Figure 2e. All data were normalized to 0 μM for each compound. Data represent mean ± s.d. (n = 3 cultures). Curves represent best fits for calculating IC50 (listed on the right panel).
Article Snippet: The
Techniques: Inhibition, Infection, Western Blot
Journal: Nature medicine
Article Title: Identification of small molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
doi: 10.1038/nm.4184
Figure Lengend Snippet: Niclosamide and PHA-690509 inhibit ZIKV infection in human astrocytes and forebrain-specific hNPCs. (a) Top, example immunostaining images of astrocytes treated with 2 μM Niclosamide, 92 μM PHA-690509, 9 μM Emricasan, or a combination of 92 μM PHA-690509 and 9 μM Emricasan for 1 hour prior to infection with PRVABC59 (MOI = 0.5). Cells were fixed 24 hours post infection and stained for ZIKVE (green) and DAPI (blue; Scale bar: 50 μm, applies to all image panels in a). Bottom, quantification of the percentage of ZIKV-infected astrocytes over DAPI. Values represent mean ± s.d. (n = 6 cultures; ***P < 0.001; One-way ANOVA for comparison with the DMSO treatment). (b) Top, example western blot images of hNPCs infected at a MOI of 0.1 and analyzed 48 hours post infection. Bottom, quantifications of NS1/GAPDH protein band intensities. Data were normalized to that with the DMSO treatment. Values represent mean ± s.d. (n = 3 cultures; ***P < 0.01; One-way ANOVA for comparison with the DMSO treatment). (c) Virus production from compound treated iPSC-derived human astrocytes. Similar to Figure 2e. Data represent mean ± s.d. (n = 3 cultures). (d–e) Summary of additive effects of a combination of Emricasan and PHA-690509 on inhibiting increased caspase-3 activity in human astrocytes infected with FSS13025-ZIKV or MR766 ZIKV (d), and on improving cell viability as measured by ATP production (e). Similar to Figure 1a. Values represent mean ± s.d. (n = 3 cultures; *P < 0.05; **P < 0.01; One-way ANOVA).
Article Snippet: The
Techniques: Infection, Immunostaining, Staining, Western Blot, Derivative Assay, Activity Assay
Journal: Science translational medicine
Article Title: Rapid Antigen Tests for Dengue Virus Serotypes and Zika Virus in Patient Serum
doi: 10.1126/scitranslmed.aan1589
Figure Lengend Snippet: (A) Table listing mAb names, mAb immunochromatography applications, mAb linear epitope sequences and starting amino acid positions, and NS1 domain positions. (B) Comparison of amino acid similarity based on analysis of NS1 protein sequences from the following viruses: DENV1- Strain Singapore/S275/1990, accession number P33478; DENV2 -Strain NGC, accession number AAA42941; DENV3- Philippines/H87/1956, accession number AAA99437; DENV4- Singapore/8976/1995, accession number AAV31422; Zika virus, accession number KU497555.1. Amino acid sequences were compared using Color Align Conservation http://www.bioinformatics.org/sms2/color_align_cons.html to enhance the output of sequence alignment program. Residues that are identical among the sequences are boxed. Linear peptide epitopes (B) are italicized and indicated in color on the figure, with the key to the right of the figure.
Article Snippet: Monoclonal antibody production strategy DENV and
Techniques: Comparison, Virus, Sequencing
Journal: Science translational medicine
Article Title: Rapid Antigen Tests for Dengue Virus Serotypes and Zika Virus in Patient Serum
doi: 10.1126/scitranslmed.aan1589
Figure Lengend Snippet: (A-B) Images of rapid test strips. Strip numbers refer to the DENV serotype NS1 (1–4), pan-dengue (P; all four DENV serotype NS1 proteins), or ZIKV virus NS1 (Z) detected. Recombinant NS1 proteins, indicated with a lower case “r’ preceding the virus name, were prepared at 500 ng/ml, and the strips were run using 50 μl of solution. Strip #1 (detects DENV serotype 1): mAb pair 912/271; Strip #2 (detects DENV serotype 2): mAb pair 243/1; Strip #3 (detects DENV serotype 3): mAb pair 411/55; Strip #4 (detects DENV serotype 4): mAb pair 626/55; Strip P (“pan dengue”; detects all four DENV serotypes): mAbs 271–243-411–626/323; Strip Z (detects ZIKV): mAbs 130/110. The test proteins run on the strips are recombinant DENV NS1, serotypes 1–4 (rDENV1-rDENV4), as well as recombinant NS1 proteins from ZIKV (rZIKV), West Nile Virus (rWNV), Yellow Fever Virus (rYFV), Japanese encephalitis virus (rJEV), and Tick Borne encephalitis virus (rTBEV). C = control, NS1 = detection site for specific NS1 protein. (C-E) Limits of detection for viral NS1 proteins using the serotype-specific (SSp) DENV strips 1–4 (C), the pan-dengue strip (D), and the ZIKV virus strip (E). The limits of detection, representing three independent determinations, are recorded on the figures. Each point (C-E) is presented as the mean and standard deviation. (F) NS1-containing supernatants from Vero cells infected with DENV serotypes 1–4 (Vs DENV1–4) or ZIKV virus (Vs ZIKV-U (Uganda) or ZIKV-B (Brazil)) were chromatographed on strips 1–4, pan-dengue (P), or ZIKV (Z) NS1 strips. The arrows indicate the strips with positive NS1 signals. Horizontal test lines (panel F) result from applying antibodies to the nitrocellulose using a mechanical striper device; the circular dot signals result from applying antibodies to the nitrocellulose using a standard pipettor.
Article Snippet: Monoclonal antibody production strategy DENV and
Techniques: Stripping Membranes, Virus, Recombinant, Control, Standard Deviation, Infection
Journal: Science translational medicine
Article Title: Rapid Antigen Tests for Dengue Virus Serotypes and Zika Virus in Patient Serum
doi: 10.1126/scitranslmed.aan1589
Figure Lengend Snippet: (A) Map showing the endemic virus regions where the rapid tests were deployed to analyze patient serum samples. The areas of the circles correlate with the numbers of samples analyzed. The blue colors, faint to dark, represent DENV serotypes 1–4. ZIKV is indicated in orange color. (B) ELISA results showing the amounts of DENV (left) and ZIKV (right) NS1 found in patient serum and supernatants from infected cell cultures. Lanes 1 and 6 are supernatants from Vero cells infected with DENV; lanes 2 and 7 are supernatants from Vero cells infected with ZIKV. Lanes 3 and 8 are PCR-negative sera; lanes 4 and 9 are sera from PCR-positive DENV patients. Lanes 5 and 10 are sera from PCR-positive ZIKV patients. (C) Images of rapid test analysis of DENV NS1 serotypes 1–4 and ZIKV NS1 on serotype specific strips 1–4, as well as pan-dengue (P) and ZIKV (Z); the upward arrows mark positive tests, and θ is serum from an uninfected patient. (D-G) Quantification of rapid test results. Dipstick tests were run with PCR-confirmed DENV sera or ELISA-validated ZIKV serum (panel C), and the resulting signals were quantified and expressed as box plots. Statistical significance, based on one one-way ANOVA, is indicated as * P < 0.05, ** P < 0.01, *** P < 0.001. (H) Statistical significance, based on an unpaired T-test, is presented as * P < 0.05. Box and whiskers plots: the black ✕ represent the maximum and minimum measured normalized intensity values, while the small square box ☐ represents the mean value, and the larger box represents the 25–75% range of the data. Individual colored points represented individual patient samples measured. (I-J) Images of rapid tests showing that DENV and ZIKV NS1 tests do not cross-react. (I) Supernatants from Vero cells infected with DENV serotype 4 were chromatographed on DENV serotype strips 1–4, on the pan-dengue strip (P), and on the ZIKV NS1 strip (Z). (J) Supernatants from Vero cells infected with ZIKV virus were chromatographed on DENV serotype strips 1–4, on the pan-dengue strip (P), and on the ZIKV NS1 strip (Z). (K) Images of rapid tests showing ZIKV NS1 is detected in serum samples concentrated 5X, but ZIKV virus NS1 is not detected in concentrated urine. Three sets of paired serum and urine samples were concentrated 5X by filter centrifugation and chromatographed on the ZIKV dipsticks. S: serum; U: urine. (I-K) The red boxes and vertical black lines serve as fiducial markers for image recognition and processing. Upward arrows indicate positive tests, using the serum samples. (L-N) Quantification of NS1 protein in supernatants of Vero cells infected separately with three DENV4 patient isolates (L) or three ZIKV patient isolates (M), or five paired serum/urine patient samples (N). Fig. 3L-N: One-way ANOVA was used to calculate statistical significance of the dengue and Zika tests: p<0.05, p<0.01, and p<.0.001 are indicated as *, **, and ***, respectively. Box and whiskers plots: the black ✕ represent the maximum and minimum measured normalized intensity values, while the black ☐ represents the mean value, and the larger box represents the 25–75% range of the data. Individual colored points represented individual patient samples measured.
Article Snippet: Monoclonal antibody production strategy DENV and
Techniques: Virus, Enzyme-linked Immunosorbent Assay, Infection, Stripping Membranes, Centrifugation
Journal: Science translational medicine
Article Title: Rapid Antigen Tests for Dengue Virus Serotypes and Zika Virus in Patient Serum
doi: 10.1126/scitranslmed.aan1589
Figure Lengend Snippet: (A) ROC curve analysis of the patient sample data collected for dengue serotypes 1–4, Dengue Pan, and Zika virus. TPR: true positive rate (sensitivity); FPR: false positive rate (1-specificity). (B) Table listing numerical values of the sensitivity and specificity results.
Article Snippet: Monoclonal antibody production strategy DENV and
Techniques: Virus
Journal: Biosensors & Bioelectronics
Article Title: A single snapshot multiplex immunoassay platform utilizing dense test lines based on engineered beads
doi: 10.1016/j.bios.2021.113388
Figure Lengend Snippet: Operation of the MOnITOR chip for one-step indirect immunoassays. (a) In the ‘Preparation’ stage, the chip immediately started to operate. (b) Engineered bead lines were secured on the reaction zone. The scale bar represents 100 μm. (c) Red-dyed sample was loaded. Trapped gas bubbles eventually diffused through the PDMS matrix (blue arrows). Wasted volumes in the loading and dummy channels consume only 1.6% of the loaded sample. (d,e) Sequentially-loaded blue-dyed buffer flowed and filled the storage chamber. During storage chamber filling, 2nd Ab was rehydrated. Rehydrated 2nd Ab diffusion toward the buffer inlet was prevented by the delaying channel. (f) When loading sample with anti-ZIKV NS1 and anti-CHIKV E2 mAb, only the corresponding beads reacted. (g) Buffer continuously flowed toward the reaction zone by contouring the empty sample inlet. (h) Unbound 2nd Ab were washed by flowing buffer. An image of the reaction zone was acquired in this stage. The scale bar represents 1 cm. (i) In the case of (f), the transferred 2nd Ab only reacted with ZIKV, CHIKV, and + beads. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet: Anti-ZIKV NS1, anti-DENV NS1, anti-CHIKV E2, and
Techniques: Diffusion-based Assay